S
Steven E. Lipshultz
Researcher at University at Buffalo
Publications - 514
Citations - 65630
Steven E. Lipshultz is an academic researcher from University at Buffalo. The author has contributed to research in topics: Cardiomyopathy & Cardiotoxicity. The author has an hindex of 102, co-authored 505 publications receiving 57200 citations. Previous affiliations of Steven E. Lipshultz include Roswell Park Cancer Institute & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Cardiotoxicity After Childhood Cancer: Beginning With the End in Mind
TL;DR: This report provides important information on late excess cardiovascular mortality in childhood cancer survivors and on the factors associated with this mortality by specifically using carefully calculated radiation doses to the heart as a factor to assess overall mortality and cardiovascular mortality.
Journal ArticleDOI
Impact of HIV and highly active antiretroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosis
TL;DR: The patients who might benefit most are those in whom the precursors of vascular plaques, such as fatty streak, smooth muscle cell, macrophage, and T-lymphocyte aggregation not yet identified by echocardiographic and biopsy findings have already developed as a result of unchecked viral inflammation and replication.
Journal ArticleDOI
Pathogenesis of HIV-associated cardiovascular complications
TL;DR: A review of HIV-associated cardiovascular complications focusing on pathogenetic mechanisms that could have a role in diagnosis, management, and therapy of these complications in the HAART era is discussed.
Journal ArticleDOI
Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation.
Anna E. Tsirka,Kathryn Trinkaus,Su Chiung Chen,Steven E. Lipshultz,Jeffrey A. Towbin,Steven D. Colan,Vernat Exil,Arnold W. Strauss,Charles E. Canter +8 more
TL;DR: Pediatric DCM patients continue to have multiple outcomes, with recovery of left ventricular systolic function occurring most frequently, and utilization of heart transplantation has led to improved survival after the diagnosis of pediatric DCM.
Journal ArticleDOI
Cardiac Morbidity and Related Mortality in Children With HIV Infection
TL;DR: The presence of encephalopathy or Epstein-Barr virus coinfection identifies HIV-infected children at especially high risk for adverse cardiac outcomes, and cardiac morbidity and mortality are more common with advanced HIV infection.